Evidence map›Paper›PMID 37908914›Full record

ArticleCureus2023

Hallucinogen-Induced Persisting Perception Disorder: A Case Report.

Javairia Ayyub, Sailaja Nandennagari, Dylan Edelbaum, Jennifer Agbo, Deenuka Nagendran, Luciano Tamayo

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 3 countries.

Javairia AyyubDepartment of Medicine, Caribbean Medical University School of Medicine, Willemstad, CUW.
Sailaja NandennagariDepartment of Behavioral Health and Psychiatry, Avalon University School of Medicine, Willemstad, CUW.
Dylan EdelbaumDepartment of Behavioral Health and Psychiatry, Windsor University School of Medicine, Cayon, KNA.
Jennifer AgboDepartment of Behavioral Health and Psychiatry, Windsor University School of Medicine, Cayon, KNA.
Deenuka NagendranDepartment of Behavioral Health and Psychiatry, Richmond Gabriel University, Arnos Vale, VCT.
Luciano TamayoDepartment of Behavioral Health and Psychiatry, Loretto Hospital, Chicago, USA.
Valve (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hallucinogen-persisting perception disorder (HPPD), also known as acute hallucinogen-induced psychosis or informally known as "flashbacks," is an unusual condition experienced by patients due to the use of different hallucinogenic substances. Hallucinogen-persisting perception disorder causes many symptoms, predominantly persistent visual perception distortion instead of intermittent distortion. Although different hallucinogens could cause HPPD, lysergic acid diethylamide (LSD) and LSD-like properties seem to be the most common hallucinogens causing the symptoms. In our case report, the patient is a 28-year-old Caucasian male with a long psychiatric and social history of polysubstance use using LSD and cannabis. He started experiencing many of the classic symptoms of HPPD seven months after stopping LSD. The diagnosis is suspected by ruling out all other possible underlying causes with the help of several laboratory and imaging tests. Despite having an extensive psychiatric history of illnesses, the patient's symptoms failed to improve with antipsychotics, confirming that the symptoms were not only due to mental illness. Although supposedly the first-line treatment for HPPD is the use of alpha-2 adrenergic drugs such as clonidine and benzodiazepines, we started to witness improvement in patient's symptoms with the use of lamotrigine, which is the gold standard in treating perceptual disturbance in time and space.

Indexed as

alpha-2 adrenergic agonistsantiepileptic medicationsbenzodiazepineshallucinogen persisting perception disorderlysergic acid diethylamidevisual perception distortion

Identifiers

PMID37908914
PMCPMC10615149
OpenAlexW4387216276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.